Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 6 of 6 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/18/20
End: 12/31/25
Due: 12/31/26
A Study of ATG-010 in Combination With Lenalidomide and Rituximab (R2) in Adults With DLBCL and iNHL
Phase: N/A
Priority: Normal
Start: 04/07/22
End: 12/31/24
Due: 12/31/25
Phase: N/A
Priority: Normal
Start: 07/12/21
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 04/09/20
End: 12/01/23
Due: 12/01/24
Phase: N/A
Priority: Normal
Start: 03/02/22
End: 02/08/23
Due: 02/08/24
Phase: N/A
Priority: Normal
Start: 09/02/19
End: 02/25/22
Due: 02/25/23